7 British Journal of Industrial Medicine 1986;43:6--17 An epidemiological study of petroleum refinery employees 0 WONG.'

(II be supplied free of variable on the pay' additional reprints ie form sent with the e Editor will not be British Journal ofIndustrial Medicine 1988;45:5-13 Mortality in miners and millers of crocidolite in Western Australia may be subject to ng. ubi , editorials commissioned.

Is mineral fiber different than asbesto Tee, mineral fiber is a material which is manufactured in our case from lead, nine and Iron slag materials. 1929?

(conoco) Interoffice Communication i. * i\ / to .

REPnoDoaBUJTT Table 1--HigkBghlt af "grsodsrdisalfso af Spiromatrj* (Statmnont by tbe American Thoracic Sociclj&) Equipment (minimum requirements) 7 titer volume Accumulate volume for 10 second* Volume accuracy 3% of reading or 50 sal, whichever i* greater Flow range 0-12 L/ace Resistance <1-5 cmHiO/L/aec at 12 L/aee flow Flow accuracy 551* of reading or 0.2 L/see, whichever ia greater T*t Performance and Measurement Minimum of 3 acceptable maneuvers, (no leaks, obstruction of mouthpiece, cough, Valsalva, or early termination) Start point defined by back extrapolation or equivalent method Back extrapolated volume <10% of FVC or 100 ml, whichever is greater Best 2 of 3 acceptable curve* vary for FVC by no more than '' 5% of leading or 100 ml, whichever is greater Bert FVC and FEVi used regardless of whether they occur on same curve attended a National Institute for Occupational Safety and Health (NIOSH) approved training course in pulmonary function testing (Table 2) to *-- pro ficient in a standardized technique for administering pulmonary function tests.

PLAINTIFF'S EXHIBIT AL-1296 FROM RICHARD A.

, SAFETY - Continued Routine dosimetry results for the month are as follows: Chemical Number PEL Percent > Number PEL Percent VCM 72 97.3 Lead 11 91.7 Total Particulates 5 100.0 2 2.7 1 8.3 0 0.0 One of the two VCM overexposures was without benefit of respiratory protection.

Scott Trial Testimony September 1, 1987 TdT?

2 -.

Three proposed safety VAB.0001191346 ai:z*t`rv-wxnrrr-, :*t, -jr:33444*9^1:-Tlfc: r SAFETY - Continued Health activity for the month was limited to routine dosimetry; results of which are shown below: the Chemical VCM Lead Total Particulates Z_ Number 77 20 2 PEL Percent 96.2 100.0 100.0 / Number 3 0 0 PEL Percent 3.8 0.0 0.0 Two of the VCM overexposures were without respiratory protection.

TO: A1 Sather/John McCulley FROM: DATE: Interoffice Communication SUBJ: T.

PLAINTIFF'S EXHIBIT UC-2239 HE--------- ASBESTOS INFORMATION ASSOCIATION 1745 Jefferson Davis Highway, Crystal Square 4, Suite 509 Arlington, Virginia 22202 (703) 979-1150 '4 ^NOTEo C^ , e. \*,, 30 May 1980 More on CPSC-EPA National Workshop On Substitutes For Asbestos As previously reported (N&N Apr.), Consumer Product Safety Commission and Environmental Protection Agency will sponsor a three-day Workshop on Substitutes for Asbestos during July 14-16, 1980.

\.

Jennings Gregory, at the 7 law offices of Fite & Miller, Anniston, Alabama 8 on the 27th day of October, 1999. 9 10 11 IT IS FURTHER STIPULATED AND AGREED that 12 the signature to and the reading of the 13 deposition by the witness is waived, the 14 deposition to have the same force and effect as 15 if full compliance had been had with all laws and OWENS 05-15-1988 Smith, Carl.txt[8/22/2017 4:10:11 PM] HARTOLDMON0036842 16 rules of court relating to the taking of 17 depositions. 18 19 20 IT IS FURTHER STIPULATED AND AGREED that 21 it shall not be necessary for any objections to 22 be made by counsel to any questions, except as to 23 form or leading questions, and that counsel for 2001 PARK PLACE, SUITE 220 BIRMINGHAM, ALABAMA 35203 1-800-888-DEPO 6 FOSHEE & TURNER COURT REPORTERS 1 the parties may make objections and assign 2 grounds at the time of trial or at the time said 3 deposition is offered in evidence or prior 4 thereto. 5 6 7 IT IS FURTHER STIPULATED AND AGREED that 8 the notice of filing of the deposition is waived. 9 10 11 12 13 OWENS 05-15-1988 Smith, Carl.txt[8/22/2017 4:10:11 PM] HARTOLDMON0036843 14 15 16 17 18 19 20 21 22 23 2001 PARK PLACE, SUITE 220 BIRMINGHAM, ALABAMA 35203 1-800-888-DEPO 7 FOSHEE & TURNER COURT REPORTERS 1 STATE OF ALABAMA, CITY OF ANNISTON, 2 OCTOBER 27, 1999, 3 3:00 PM., 4 5 CARL SMITH, 6 having been first duly sworn, was examined and 7 testified as follows: 8 9 COURT REPORTER: Usual stipulations 10 okay?

Liver Angiosarcoma Cases -C^^- URL 15923 5// /- Circulation Dr K S Williamson * Dr G Paddle Dr D P DuffleId Dr W G F Adams - (5 copies - IC1A Mr G J Sleddon/Mr J B M Sheaff Dr D W Plester Mr L F 11111, Mlllbank Mr Brian llasler, Vlnatex Mr A E 11 Williams, DP Mr R H Hards, BIP Dr J T Carter, BP Mr T L Phillips, BP Dr P Lewis, CIA Dr J R Tassignon, Solvay Mr J C Thomas, Rhone~Poulenc Dr Renzo Mattiussl, Montedison Mr M Bonnefoy, Solvay Dr B List, Lonza Mr P C Claus, APME Dr J G Kamtmiller, Shell Dr L de Boer, Shell Mr S Wejdltng, Kemanord Mr C Rangnes, Norsk Hydro Dr Terwiesch, CWU Mr H Emminger, VKE Mr P de Voogd, Shell Dr E Lloyd-Jones, BP Mr Owen Jones, Hillhouse Dr Brian Bennett, Hillhouse Dr Peter Wright, PCD Wilton Dr F W Best, Everberg Dr G Norcross, Everberg Mr C DMlaenens, APME Dr C Bishop, EMAS Mr B Werner, EMAS Dr Spirtas - N10SH, Cincinatti Ms R Kaminski - HIOSH, Cincinatti (tfarfiL/VW* AECI, Duperial) R E C r.1V " JUN 10 1980 (Yirntr Dr J Stafford (8) Dr 11 Torkelson, Dow Lawrence, SPI T Seawell, CMA Washington Mr R N Wheeler, UCC Dr A Ross Adams, Air Products Dr Mayo Smith, Air Products 5O / '1 IV" -IS ^ <> 1 1 eCOg ^ Dr John Barr, Air Products Dr Walter D Harris, Uniroyal Inc Dr Robert K Hinderer, BF Goodrich (Cleveland) Dr R A Krueger, BF Goodrich Dr M N Johnson, BF Goodrich Dr J Possberg, Wacker Dr Rety, RP, St Fons Dr Lazard, RP, St Auban Dr A Friedel, Berufsgenossenschaft der chemlschen Industrie, Heidelberg Prof Dr Thiess, BASF Dr D M Ferguson, ICI Americas Mr D Ryerson, ICI Americas Mr A J Wheeler, ICI Americas Mr M J S Gibbons ICI Americas Dr Cary Ter llaar.